The public health problem caused by hepatitis B virus (HBV) is of worldwide importance since the chronic carrier state in Far East Asia and tropical Africa represents 10% or more of the population and chronic active hepatitis and liver cirrhosis are major causes of mortality. HBV infection can generally be prevented by vaccination. However, reliable treatments for the approximately 200 million HBV chronic carriers worldwide are currently unavailable. The elimination of replicating virus from chronic carriers might be achieved by inhibiting viral transcription, an essential step in the replication cycle of the virus. Therefore, a detailed understanding of the mechanisms regulating the expression of the HBV transcription units may suggest rational approaches to disrupting this step in the viral life cycle. The nucleotide sequence elements in the 3.2kb HBV genome involved in regulating the expression of the four viral transcription units will be examined in a variety of liver and non-liver cell lines using transient transfection assays and in vitro transcription systems. A series of promoter deletions will be constructed for the major surface antigen, large surface antigen, nucleocapsid antigen and X genes and examined for transcriptional activity by measuring RNA levels and/or reporter gene activities directed by these regulatory sequence elements. A detailed examination of the transcriptional regulatory elements of these genes will be performed by characterizing the effects of clustered and single point mutations on the activities of the HBV promoters. The factors present in various cell extracts that bind to the HBV regulatory sequences will be examined using gel retardation and Dnasel footprinting assays. The results of the transcriptional analysis and the DNA binding assays will be compared to determine any correlations between these two activities. This analysis may indicate the presence of regulatory sequence elements which interact with hepatocyte specific transcription factors and therefore may contribute to HBV liver tropism. The sequence elements necessary for transcriptional modulation of the HBV promoter activities by glucocorticoids and transforming growth factor p will also be examined. Defining the HBV promoter regulatory sequence elements and detection of sequence specific DNA binding factors represents an initial step towards the characterization and cloning of the genes encoding these transcription factors. The cloning of the genes for these factors will permit the analysis of the mechanism by which these factors interact with their recognition sequences and influence the transcriptional activity of the HBV promoters.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030070-05
Application #
2065428
Study Section
Experimental Virology Study Section (EVR)
Project Start
1991-07-01
Project End
1997-10-30
Budget Start
1995-05-01
Budget End
1997-10-30
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
McFadden, Vanessa C; Shalaby, Rasha E; Iram, Saira et al. (2017) Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation. PLoS Pathog 13:e1006239
Reese, Vanessa C; Oropeza, Claudia E; McLachlan, Alan (2013) Independent activation of hepatitis B virus biosynthesis by retinoids, peroxisome proliferators, and bile acids. J Virol 87:991-7
Reese, Vanessa C; Moore, David D; McLachlan, Alan (2012) Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo. J Virol 86:2760-8
Ondracek, Caitlin R; McLachlan, Alan (2011) Role of peroxisome proliferator-activated receptor gamma coactivator 1alpha in AKT/PKB-mediated inhibition of hepatitis B virus biosynthesis. J Virol 85:11891-900
Reese, Vanessa; Ondracek, Caitlin; Rushing, Christel et al. (2011) Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int J Biochem Cell Biol 43:230-7
Ondracek, Caitlin R; Reese, Vanessa C; Rushing, Christel N et al. (2009) Distinct regulation of hepatitis B virus biosynthesis by peroxisome proliferator-activated receptor gamma coactivator 1alpha and small heterodimer partner in human hepatoma cell lines. J Virol 83:12545-51
Li, Lie; Oropeza, Claudia E; Sainz Jr, Bruno et al. (2009) Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha. PLoS One 4:e5489
Ondracek, Caitlin R; Rushing, Christel N; Reese, Vanessa C et al. (2009) Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis. J Virol 83:12535-44
Li, Lie; Oropeza, Claudia E; Kaestner, Klaus H et al. (2009) Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice. J Virol 83:1682-8
Oropeza, Claudia E; McLachlan, Alan (2007) Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency. Virology 359:371-81